跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,660 条关于
“Samsung C&T”
全部
28,660
临床试验
13,750
药物
5,146
机构
3,106
资讯
6,658
11个月前
Samsung Invests $110 Million in GRAIL to Bring Multi-Cancer Blood Test to Asia
去年
Samsung Invests $10 Million in C2N Diagnostics to Advance Brain Health Diagnostics
6个月前
C2N Diagnostics Expands Alzheimer's Blood Test Access Across Asia Through Strategic Partnerships
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
Samsung Bioepis to Become Wholly-Owned Subsidiary of Samsung Biologics in Strategic Restructuring
去年
Samsung Biologics Expands Into Preclinical Research with Launch of Samsung Organoids Drug Screening Platform
9个月前
Samsung Biologics Reaches 400 Global Manufacturing Approvals, Reinforcing CDMO Leadership
去年
Samsung Bioepis' Opuviz (Eylea Biosimilar) Receives European Commission Approval
去年
European Commission Approves Samsung Bioepis' Aflibercept Biosimilar, OPUVIZ
去年
European Commission Approves Samsung Bioepis' Aflibercept Biosimilar, OPUVIZ
第 1 页,共 666 页
上一页
下一页